Utilization of homologous proteins to evaluate the safety of recombinant human proteins — case study: recombinant human interferon-gamma (rhIFN-γ)
- 1 December 1992
- journal article
- Published by Elsevier in Toxicology Letters
- Vol. 64-65, 321-327
- https://doi.org/10.1016/0378-4274(92)90204-w
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous DiseaseNew England Journal of Medicine, 1991
- Effects of recombinant murine interferon-? on pregnant mice and their fetusesFundamental and Applied Toxicology, 1990
- The preclinical development of roferon®-ACancer, 1986
- Toxicity of interferon.BMJ, 1981